RxDoctor Payments Data

Kristin Mix

Nurse Practitioner · Knoxville, TNNPI 1730173261

Payments from drug & device makers

$614in general payments, 2019–2025

Across 28 payments — averaging $21.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$124
  • Sanofi-aventis U.S. LLC$95
  • Regeneron Healthcare Solutions, Inc.$76
  • AstraZeneca$67
  • CSL Behring$59
  • Kaleo, Inc.$36
  • plus $156 from 7 others

What the payments were for

  • Food & beverage$46275%
  • Education$15225%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$614 in reported general payments places this provider in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$251,730
Medicare patients
255
Services billed
8,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter85$94,507
HizentraImmun Glob G(Igg)/Pro/Iga 0-5011$87,930
Dupixent SyringeDupilumab15$60,272
Dupixent PenDupilumab15$58,760
Breo ElliptaFluticasone/Vilanterol37$19,721
Spiriva RespimatTiotropium Bromide28$16,332
Arnuity ElliptaFluticasone Furoate18$7,424
Epinephrine37$7,364
Azelastine Hcl120$4,575
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$4,259
Qvar RedihalerBeclomethasone Dipropionate11$3,096
Ipratropium Bromide62$2,869
RyaltrisOlopatadine Hcl/Mometasone11$2,844
Fluticasone Propionate121$2,105
Albuterol Sulfate HfaAlbuterol Sulfate57$1,357

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$124$121,652140 claims
CSL BehringHizentra$59$87,93011 claims
Boehringer IngelheimSpiriva Respimat$15$16,33228 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →